Skip to content

Inspiratory Muscle Training in Individuals With Cystic Fibrosis

Effects of Inspiratory Muscle Training in Individuals Who Have Cystic Fibrosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03737630
Enrollment
10
Registered
2018-11-09
Start date
2019-08-05
Completion date
2020-01-31
Last updated
2020-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis

Keywords

cystic fibrosis, quality of life, posture

Brief summary

Cystic fibrosis is a genetic disease that affects some organs of the human body. Among them, the lungs tend to be the most affected due to the accumulation of mucus in the airways, which in addition to avoiding the passage of air, favors pulmonary infections. With the evolution of the condition, secondary complications arise, such as postural changes, decreased respiratory muscle strength, decreased functional capacity and, consequently, quality of life. Therefore, respiratory muscle training may be an intervention that improves the respiratory condition of these individuals, allowing an improvement in the quality of life and may delay the evolution of respiratory symptoms. Thus, this study aims to investigate a home protocol of respiratory muscle training on respiratory muscle strength, lung function, quality of life, posture and functional capacity in adolescents and adults with cystic fibrosis. The researchers believe that the training can cause an improvement in the studied variables, and can be inserted in the usual treatment of these patients.

Interventions

DEVICEInspiratory muscle training

This group will initiate inspiratory muscle training with 40% of the MIP load and each week will have a load increase of 10% of the initial MIP up to 4 weeks of training

Sponsors

Universidade Federal do Rio Grande do Norte
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
14 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of cystic fibrosis, confirmed by the sweat test; * 14 - 25 years; * Clinical stability; * Absence of bacterial colonization for 4 weeks; * Both sexes;

Exclusion criteria

* Inability to perform the protocol established by the study; * Present any intercurrence during data collection; * Being unable to understand and / or perform procedures. * Colonization during study participation; * Patient hospitalization due to worsening of the clinical picture.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline Health-related quality of life at 4 weeksBaseline and after 4 weeks of trainingHealth-related quality of life questionnaire (HRQoL)
Change from baseline Posture at 4 weeksBaseline and after 4 weeks of trainingInclinometer Danoplus®

Secondary

MeasureTime frameDescription
Change from baseline Respiratory muscle strength at 4 weeksBaseline and after 4 weeks of trainingMVD300®
Change from baseline Pulmonary function at 4 weeksBaseline and after 4 weeks of trainingSpirometry test using Koko® device
Change from baseline Functional capacity at 4 weeksBaseline and after 4 weeks of trainingthree-minute step test

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026